OPRC_Banner_Logo

ALERT BAR

Dates


Publications


Publications

  • Opioid exposure and birth defects

    Haas, D. M. (2011). Opioid exposure and birth defects. American Journal of Obstetrics and Gynecology, 205(3): e9-e10. author reply e10-1, doi: 10.1016/j.ajog.2011.06.031. (PMID: 22071073)
  • Maternal serum folate species in early pregnancy and lower genital tract inflammatory milieu

    Simhan, H. N., Himes, K. P., Venkataramanan, R., & Bodnar, L. M. (2011). Maternal serum folate species in early pregnancy and lower genital tract inflammatory milieu. American Journal of Obstetrics and Gynecology, 205(1), 61.e1-e7. doi: 10.1016/j.ajog.2011.03.039. (PMID: 21600548)
  • Pharmacokinetics of Oseltamivir among pregnant and non-pregnant women

    Beigi, R. H., Kelong, H., Venkataramanan, R., Hankins, G. D., Clark, S., Herbert, M. F., Easterling, T., Zajicek, A., Ren, Z., Mattison, D. R., & Caritis, S. N. (2011). Pharmacokinetics of Oseltamivir among pregnant and non-pregnant women. American Journal of Obstetrics and Gynecology, 204(6 Suppl 1), S84-8. doi: 10.1016/j.ajog.2011.03.002. (PMID: 21492826)
  • Pharmacotherapeutic management of nicotine dependence in pregnancy

    Clark, S. M., & Nakad, R. (2011). Pharmacotherapeutic management of nicotine dependence in pregnancy. Obstetrics and Gynecology Clinics of North America, 38(2), 297-311. doi: 10.1016/j.ogc.2011.02.017. (PMID: 21575802)
  • Pharmacotherapy and pregnancy: Highlights from the Third International Conference for Individualized Pharmacotherapy in Pregnancy

    Haas, D. M., Gallauresi, B., Shields, K., Zeitlin, D., Clark, S. M., Hebert, M. F., Ren, A., Nallani, S. C., Meslin, E. M., Feibus, K. B., Koren, G., Goebel, W. S., Easterling, T., Denne, A. C., Flockhart, D. A., & Renbarger, J. L. (2011). Pharmacotherapy and pregnancy: Highlights from the Third International Conference for Individualized Pharmacotherapy in Pregnancy. Clinical and Translational Science, 4(3), 204-9. doi: 10.1111/j.1752-8062.2011.00280.x. (PMID: 21707952)
  • Human breast milk as a source of DNA for amplification

    Haas, D. M., Daum, M., Skaar, T., Philips, S., Miracle, D., & Renbarger, J. L. (2011). Human breast milk as a source of DNA for amplification. Journal of Clinical Pharmacology, 51(4), 616-9. doi: 10.1177/0091270010370847. (PMID: 20498289)
  • Collection of human genomic DNA from neonates: A comparison between umbilical cord blood and buccal swabs

    Lehmann, A. S., Haas, D. M., McCormick, C. L., Skaar, T. C., & Renbarger, J. L. (2011). Collection of human genomic DNA from neonates: A comparison between umbilical cord blood and buccal swabs. American Journal of Obstetrics and Gynecology, 204(4), 362.e1-6. doi: 10.1016/j.ajog.2010.12.013. (PMID: 21324432)
  • Gestational diabetes mellitus alters maternal and neonatal circulating endothelial progenitor cell subsets

    Acosta, J. C., Haas, D. M., Saha, C. K., Dimeglio, L. A., Ingram, D. A., & Haneline, L. S. (2011). Gestational diabetes mellitus alters maternal and neonatal circulating endothelial progenitor cell subsets. American Journal of Obstetrics and Gynecology, 204(3), 254.e8-e15. doi: 10.1016/j.ajog.2010.10.913. (PMID: 21167470)
  • Maternal ethnicity influences on neonatal respiratory outcomes after antenatal corticosteroid use for anticipated preterm delivery

    Haas, D. M., Sischy, A. C., McCullough, W., & Simsiman, A. J. (2011). Maternal ethnicity influences on neonatal respiratory outcomes after antenatal corticosteroid use for anticipated preterm delivery. The Journal of Maternal-Fetal & Neonatal Medicine, 24(3), 516-20. doi: 10.3109/14767058.2010.506228. (PMID: 20672908)
  • Pharmacokinetics of metronidazole in pregnant patients with bacterial vaginosis

    Wang, X., Nanovskaya, T. N., Zhan, Y., Abdel-Rahman, S. M., Jasek, M. B., Hankins, G. D. V., & Ahmed, M. S. (2011). Pharmacokinetics of metronidazole in pregnant patients with bacterial vaginosis. The Journal of Maternal-Fetal & Neonatal Medicine, 24(3), 444-448. doi: 10.3109/14767058.2010.497573. (PMID: 20608802)
  • Pregnancy decreases rat CYP1A2 activity and expression

    Walker, A. A., Dickmann, L., & Isoherranen, N. (2011). Pregnancy decreases rat CYP1A2 activity and expression. Drug Metabolism and Disposition, 39(1), 4-7. doi: 10.1124/dmd.110.035766. (PMID: 20921303)
  • Pharmacokinetics of indomethacin in pregnant women with preterm labor

    Wang, X., Rytting, E., Nanovskaya, T. N., Patrikeeva, S. L., Clark, S., Jasek, M. B., Venkataramanan, R., Caritis, S., Hankins, G. D. V., & Ahmed, M. S. (2011). 180: Pharmacokinetics of indomethacin in pregnant women with preterm labor. American Journal of Obstetrics & Gynecology, Volume 204 , Issue 1 , S83. doi: http://dx.doi.org/10.1016/j.ajog.2010.10.196.
  • Pharmacokinetics of famotidine in pregnant women

    Wang, X., Zhan, Y., Rytting, E., Patrikeeva, S. L., Nanovskaya, T. N., Clark, S., Jackson, A., Venkataramanan, R., Caritis, S., Hankins, G. D. V., & Ahmed, M. S. (2011). 150: Pharmacokinetics of famotidine in pregnant women. American Journal of Obstetrics & Gynecology, Volume 204, Issue 1, S72–S73. doi: http://dx.doi.org/10.1016/j.ajog.2010.10.166.
  • From no to yes: The history and ethics of including pregnant women in clinical trials

    Haas, D. M. (2011). From no to yes: The history and ethics of including pregnant women in clinical trials. Clinical Investigation, 1(10), 1349-51. doi: 10.4155/CLI.11.125.
  • The placenta as a functional barrier to fetal drug exposure

    Nanovskaya, T. N., Hankins, G. D. V., & Ahmed, M. S. (2011). The placenta as a functional barrier to fetal drug exposure. In H. Kay, D. M. Nelson, & Y. Wang (Eds.), The placenta from development to disease, Hoboken, NJ: Wiley-Blackwell, 303-9.